In experimental autoimmune encephalomyelitis (EAE) in mice, blocking CD80/CD86 molecules with CTLA-4Ig increased disease score with increased production of interleukin-17 (IL-17) and interferon-γ (IFN-γ). Here, IL17A is linked to experimental autoimmune encephalomyelitis.